title: Comparison of low-dose intramuscular and intravenous salcatonin in the treatment of primary hyperparathyroidism.
abstract: The treatment of hypercalcaemia with low-dose salcatonin (100 U/d), administered either as a single intramuscular bolus or as a continuous intravenous infusion for five days, was examined in two groups of 10 patients with primary hyperparathyroidism, in a randomized open parallel study. Both the peak (0.31 +/- 0.035 mmol/L v 0.13 +/- 0.034 mmol/L) and overall (0.073 +/- 0.016 mmol/L v 0.018 +/- 0.016 mmol/L) hypocalcaemic responses were greater in the infusion group. The peak reduction in serum calcium occurred on day 2 of treatment after which there was a progressive attenuation of response. All the differences between the two methods of administration wer due to renal rather than bony effects of salcatonin. Possible causes of progressive resistance to treatment included reductions in sodium excretion and serum phosphate. It is concluded that low-dose salcatonin administered as a continuous infusion was more effective than the same dose given as a bolus. The kidney played a pivotal role both in the cause of the hypercalcaemia and in the response to treatment, including the rapid development of resistance which limits the use of salmon calcitonin in primary hyperparathyroidism to short-term reduction of serum calcium.
authors.affiliation: University Hospital, Nottingham, England.
authors.forename: M D
authors.initials: MD
authors.lastname: Stone
authors.forename: D H
authors.initials: DH
authors.lastname: Marshall
authors.forename: D J
authors.initials: DJ
authors.lastname: Hosking
authors.forename: C
authors.initials: C
authors.lastname: Garcia-Himmelstine
authors.forename: D A
authors.initials: DA
authors.lastname: White
authors.forename: H G
authors.initials: HG
authors.lastname: Worth
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood; D002116:Calcitonin / Q000008:administration & dosage* / Q000627:therapeutic use; D002118:Calcium / Q000097:blood*; D003404:Creatinine / Q000097:blood; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D006961:Hyperparathyroidism / Q000097:blood / Q000188:drug therapy*; D007262:Infusions, Intravenous; D007273:Injections, Intramuscular; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D011897:Random Allocation
chemical_list: D010281:Parathyroid Hormone; D010710:Phosphates; C028815:salmon calcitonin; D002116:Calcitonin; D003404:Creatinine; D000469:Alkaline Phosphatase; D002118:Calcium